Home / Events / Global Life Sciences & Healthcare Forum 2022

Global Life Sciences & Healthcare Forum 2022

Uncertain times, an evolving legal framework: managing risks and ensuring social responsibility in the life sciences & healthcare sector

Past event
29 September 2022, 10:00 - 18:30 UTC +01:00

Join us for our Global Life Sciences & Healthcare Forum!  The Forum being both in person and online.

With the sector looking closer at the impact it is having on the environment and social needs, as well as the role governance plays in how it conducts business, we will explore:

  • Keynote speaker: Amitrajit Saha, Team Leader, Africa HIV, Health & Development Team, United Nations Development Programme
  • Environmental sustainability: pitfalls and opportunities in a tightening regulatory framework
    • ESG as a value creation lever in the Life Sciences sector in Europe
    • Sustainability Claims: legal challenges and best practices
Speakers

  • Jan-Frederik Jerratsch, Managing Director & Partner, Boston Consulting Group
  • Charline Wurzer, Principal, Boston Consulting Group
  • CMS specialists

 

  • Social responsibility and improving access to health: navigating the legal challenges The proposed EU Directive on Supply Chain Due Diligence: what to expect?
  • Bridging the health gap: facilitating access to health with telemedicine, digital tools, virtual reality
Speakers

  • CMS specialists

 

We will also discuss how increasing levels of risk over the last year have impacted the sector, including:

  • Keynote speaker: Martin Gallizia, Multinational Client Director, and head of Chemie/Pharma/Medtech DACH, AON
  • Technology Transformation
    • CMS Report on Technology Transformation: Managing Risks in a Changing Landscape:  New technologies give rise to new risks. Managing these risks should be a priority, but adequate measures still need to be developed. We report on our findings as they relate to the life sciences & healthcare sector.
    • Insuring IP risks: An insurer’s approach to assessing and mitigating IP risks, and the challenges and opportunities in this area.
Speakers

  • Paul Wishart, Managing Director, Sybaris
  • CMS specialists

 

  • A changing commercial landscape
    • Supply chain disruption and contractual hardship / termination: Best practices and considerations in the context of pandemic and war; Shortage of resources and rising inflation: Pricing and competition developments.
Speakers

  • Laetitia Szaller, General Counsel & VP Business Development, AM Pharma
  • Omina Technologies
  • CMS specialists

To register for either in person and online, click the options below. The Forum is free to attend.

Programme

TimeItem
10.00 – 10.05Opening
Nick Beckett, Global Co-Head of CMS Life Sciences & Healthcare Sector Group
10.05 – 10.30

Keynote: ESG
Amitrajit Saha, Team Leader, Africa HIV, Health & Development Team, United Nations Development Programme

10.30 – 11.30Environmental sustainability: pitfalls and opportunities in a tightening regulatory framework 
• ESG as value creation lever in the Life Sciences sector in Europe 
• Sustainability claims: Legal challenges and best practices 
11.30 – 12.00Coffee break
12.00 – 13.00Social responsibility and improving access to health: navigating the legal challenges
• The proposed EU Directive on Supply Chain Due Diligence: what to expect? 
• Bridging the health gap: facilitating access to health with telemedicine, digital tools, virtual reality  
13.00 – 14.30Lunch
14.30 – 15.00Keynote: Managing Risk
Martin Gallizia, Multinational Client Director, and head of Chemie/Pharma/Medtech DACH, AON
15.00 – 16.00Technology transformation
• Technology Transformation: Managing Risks in a Changing Landscape
• Q&A/Fireside chat – Insuring IP risks
16.00 – 16.30Coffee
16.30 – 17.30A changing commercial landscape: current risks and challenges 
17.30 – 17.35Closing
Jens Wagner, Global Co-Head of CMS Life Sciences & Healthcare Sector Group
17.35 – 18.30Drinks

Should you have any questions regarding this Forum, please contact us.

Hosts

Nick Beckett
Nick Beckett
Managing Partner
Managing Partner, Beijing and Hong Kong Offices, Head of Asia-Pacific IP and Life Sciences & Healthcare
Beijing
Jens Wagner
Dr. Jens Wagner
Partner
Rechtsanwalt | Chair of the CMS Life Sciences & Healthcare Group
Hamburg

Morning session: ESG

With the sector looking closer at the impact it is having on the environment and social needs, as well as the role governance plays in how it conducts business, we will explore:

  • Keynote speaker: UN representative
  • Environmental sustainability: pitfalls and opportunities in a tightening regulatory framework
    • ESG as a value creation leaver in the Life Sciences sector in Europe
    • Sustainability Claims: legal challenges and best practices
    • The proposed EU Directive on Supply Chain Due Diligence: what to expect?
Speakers

  • Jan-Fredrik Jerratsch, Boston Consulting Group 
  • Charline Wurzer, Boston Consulting Group
  • CMS specialists

 

  • Improving access to health: navigating the legal challenges
    • Bridging the health gap: facilitating access to health with telemedicine, digital tools, virtual reality
    • Access to medicine: alternative models of distribution of medicine
    • Equity in life sciences/clinical studies
Speakers

  • CMS specialists

Our morning session speakers

Roland Wiring
Dr. Roland Wiring
Partner
Rechtsanwalt | Fachanwalt für Medizinrecht (Certified lawyer for medical law) | Co-Head of the CMS Life Sciences & Healthcare Group
Hamburg
Gabriela Staber
Gabriela Staber
Partner
Vienna
Kenny Henderson
Kenny Henderson
Partner
London

Afternoon session: Managing risk

We will also discuss how increasing levels of risk over the last year have impacted the sector, including:

  • Keynote speaker: Martin Gallizia, Multinational Client Director, and head of Chemie/Pharma/Medtech DACH, AON
  • Technology Transformation CMS Report on Technology Risks: New technologies give rise to new risks. Managing these risks should be a priority, but adequate measures still need to be developed. We report on our findings as they relate to the life sciences & healthcare sector
    • Insuring IP risks: An insurer’s approach to assessing and mitigating IP risks, and the challenges and opportunities in this area
Speakers

  • Paul Wishart, Sybaris
  • CMS specialists

 

  • A changing commercial landscape
    • Supply chain disruption and contractual hardship / termination: Best practices and considerations in the context of pandemic and war; Shortage of resources and rising inflation: Pricing and competition developments
Speakers

  • Laetitia Szaller, General Counsel & VP Business Development, AM Pharma
  • CMS specialists

Our afternoon session speakers

Show more Show less
Thomas Hirse
Dr. Thomas Hirse
Partner
Rechtsanwalt
Duesseldorf
Louise Boswell
Louise Boswell
Partner
Solicitor Advocate
London
Jeremy Mash
Jeremy Mash
Partner
London
Jane Hollywood
Jane Hollywood
Partner
Patent Attorney
London
Brian Sher
Brian Sher
Partner
Head of Antitrust, Competition and Trade
London

Event location

The EGG
Rue Bara 175
1070 Brussels
Belgium
Open Google Maps